Literature DB >> 19877249

Characteristics and management of splenic artery aneurysms in adult living donor liver transplant recipients.

Deok-Bog Moon1, Sung-Gyu Lee, Shin Hwang, Ki-Hun Kim, Chul-Soo Ahn, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gi-Young Ko, Kyu-Bo Sung.   

Abstract

Splenic artery aneurysms (SAAs), occurring in 7% to 17% of patients with cirrhosis, often result in catastrophic rupture after liver transplantation. We had experienced 3 cases of ruptured SAAs after adult living donor liver transplantation (LDLT), and we then performed this study to find risk factors for coexisting SAAs in liver transplant candidates with cirrhosis and to propose ideal approaches for them. Preoperative and postoperative computed tomography angiograms and axial views were reviewed for 310 adult LDLT recipients who had cirrhosis from January 2004 to August 2005. The recorded variables were the preoperative diagnosis, the presence of SAA and its characteristics, the splenic artery (SA) diameter, and the presence and size of portosystemic collaterals. Devastating SAA rupture accompanied by hypovolemic shock occurred on postoperative days 6, 82, and 8, respectively, and it was treated emergently by embolization in cases 1 and 2 and by splenectomy in case 3. Cases 1 and 3 recovered well, but case 2 died of an unrelated cause with a long hospital stay. The incidence of SAA during the study period was 14.2% (44/310), and the size was 16.6 +/- 5.7 mm. Most SAAs were single (70.6%, 31/44) and were located in the distal one-third of the SA (82.4%, 36/44). Large portosystemic collaterals demonstrating longstanding severe portal hypertension were significantly correlated with the occurrence of SAAs. Nine patients with SAAs were preventively treated by proximal ligation (n = 4) intraoperatively and by embolization (n = 5) 1 day before or after LDLT. No patient showed severe postembolization syndrome. In conclusion, a careful preoperative evaluation of SAAs by high-resolution 3-dimensional computed tomography in liver transplant candidates, especially in those showing large portosystemic collaterals, is merited. Preventive treatment should be encouraged regardless of the size in order to avoid severe morbidity and mortality related to SAA rupture, and methods such as radiological and surgical interventions need to be individualized according to the location and number of SAAs.

Entities:  

Mesh:

Year:  2009        PMID: 19877249     DOI: 10.1002/lt.21885

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  6 in total

1.  Multidetector CT-guided endovascular treatment of a splenic artery aneurysm in a child with split-liver transplant and surgically ligated splenic artery origin.

Authors:  Settimo Caruso; Roberto Miraglia; Vincenzo Carollo; Luigi Maruzzelli; Angelo Luca
Journal:  Pediatr Radiol       Date:  2012-03-09

Review 2.  A review of management options for splenic artery aneurysms and pseudoaneurysms.

Authors:  Hse Juinn Lim
Journal:  Ann Med Surg (Lond)       Date:  2020-09-09

3.  Visceral artery aneurysms in liver transplant candidates and in patients after liver transplantation.

Authors:  Umberto Maggi; Daniele Dondossola; Dario Consonni; Stefano Gatti; Rossella Arnoldi; Manuela Bossi; Giorgio Rossi
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

4.  Ruptured Visceral Artery Aneurysms: A Deadly Cause of Epigastric Pain.

Authors:  Sara Bradley; Faith Quenzer; Micah Wittler
Journal:  Clin Pract Cases Emerg Med       Date:  2019-02-26

5.  Transcatheter Arterial Embolization of Splenic Artery Aneurysms: A Single-Center Experience.

Authors:  Taein Yoon; Taewon Kwon; Hyunwook Kwon; Youngjin Han; Yongpil Cho
Journal:  Vasc Specialist Int       Date:  2014-12-31

Review 6.  Living donor liver transplantation for idiopathic portal hypertension with extrahepatic portal vein stenosis and splenic artery aneurysms: a case report and review of the literature.

Authors:  Shigeyuki Kawachi; Naokazu Chiba; Masashi Nakagawa; Toshimichi Kobayashi; Kosuke Hikita; Toru Sano; Koichi Tomita; Hiroshi Hirano; Yuta Abe; Hideaki Obara; Motohide Shimazu
Journal:  BMC Surg       Date:  2020-10-29       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.